81
Views
0
CrossRef citations to date
0
Altmetric
Research

Using government data to understand the use and availability of medicines for hypertension and diabetes: lessons from Peru

, , , & ORCID Icon
Article: 86 | Received 26 Sep 2022, Accepted 02 Nov 2022, Published online: 04 Dec 2023

Figures & data

Fig. 1 Quantity of doses delivered per month between January 2015 to December 2020 for Losartan 50 mg and Metformin 850 mg. A Primary level of care, B secondary level of care, and C tertiary level of care

Fig. 1 Quantity of doses delivered per month between January 2015 to December 2020 for Losartan 50 mg and Metformin 850 mg. A Primary level of care, B secondary level of care, and C tertiary level of care

Fig. 2 Availability per month between January 2015 and December 2020 in the all the levels of care. A Losartan 50 mg and B metformin 850 mg

Fig. 2 Availability per month between January 2015 and December 2020 in the all the levels of care. A Losartan 50 mg and B metformin 850 mg
Supplemental material

Additional file 1: Table 1a.

Download MS Word (18 KB)

Availability of data and materials

Data for analysis are in the public domain. The data that support the finding of this study are available from the Peruvian National Regulatory Agency (Dirección General de Medicamentos Insumos y Drogas—DIGEMID, in Spanish), which provides a monthly updated repository of Availability of Pharmaceutical Products available in the following link: https://www.digemid.minsa.gob.pe/category/disponibilidad-productos-farmaceuticos